DEA

The New Hampshire Medical Society and ACLU say the state should continue to fight a federal law enforcement request for access to the state’s prescription drug database.

The dispute stems from a subpoena issued last June by the DEA to New Hampshire’s prescription drug monitoring program, which tracks doctor and patient prescriptions for certain controlled substances.

Prescription Drug Treatment Info / Flickr/CC

The New Hampshire Attorney General’s office is blocking a request by federal law enforcement agents to turn over drug prescribing information collected by the state.

In June, the Drug Enforcement Administration served a subpoena to Michelle Ricco-Jonas, program manager for the New Hampshire Prescription Drug Monitoring Program.